Traws Pharma
TRAW
12 hedge funds and large institutions have $8.23M invested in Traws Pharma in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
8% less funds holding
Funds holding: 13 → 12 (-1)
26% less capital invested
Capital invested by funds: $11.1M → $8.23M (-$2.83M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
91% less call options, than puts
Call options by funds: $4K | Put options by funds: $43K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.14M |
| 2 |
Citigroup
New York
|
+$285K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$285K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$285K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$569K |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$324K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$285K |
| 4 |
Goldman Sachs
New York
|
-$285K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$285K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $8K | – | – | – |
|
27
Barclays
London,
United Kingdom
| $6K | – | – | – |
|
28
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $6K | – | – | – |
|
|
DA
29
Dunvegan Associates
Santa Barbara,
California
| $2K | – | – | – |
|
|
NFG
30
Next Financial Group
Houston,
Texas
| $2K | – | – | – |
|
|
U
31
UBS
Zurich,
Switzerland
| $2K | – | – | – |
|
32
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $3 | – | – | – |
|
|
TC
33
TFS Capital
West Chester,
Pennsylvania
| – | -$324K | -1 | Closed |
|
34
Bank of America
Charlotte,
North Carolina
| – | -$139K | – | – |
|
35
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | – | – |
|
|
COPPSERS
36
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
| – | -$92K | – | – |
|
|
CS
37
Credit Suisse
Zurich,
Switzerland
| – | -$61K | – | – |
|
|
LP
38
LMR Partners
London,
United Kingdom
| – | -$70K | – | – |
|
|
PP
39
Paloma Partners
Greenwich,
Connecticut
| – | -$138K | – | – |
|
|
SFM
40
Soros Fund Management
New York
| – | -$59K | – | – |
|
41
Two Sigma Investments
New York
| – | -$58K | – | – |
|
TRAW Hedge Fund Activity: Q3 2014 in Review
12 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q3 2014, worth a combined $8.23M — down 26% from $11.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TRAW and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Great Point Partners, adding an estimated $1.14M. The largest seller was Renaissance Technologies, cutting an estimated $569K.
- 12 institutional investors held Traws Pharma (TRAW) as of Q3 2014, down from 13 in Q2 2014.
- Funds reported $8.23M of Traws Pharma stock for Q3 2014, down 26% quarter-over-quarter.
- 2 funds opened new Traws Pharma positions in Q3 2014 and 3 closed out, a net change of -1 holder.
- The largest Traws Pharma buyer in Q3 2014 was Great Point Partners, an estimated $1.14M added.
- The largest Traws Pharma seller in Q3 2014 was Renaissance Technologies, an estimated $569K sold.
Based on aggregated 13F filings for Q3 2014.